プログラム委員会
-
Kiyoshi Okada, MD, PHD Professor , Deputy Director, Regenerative Medicine Support Office, Future Medica
the University of Osaka & the University of Osaka Hospital, Japan -
Hiromi Okabe, PHD Oncology & Rare Disease, Regulatory Strategy, Regulatory Affairs
Amgen K.K., Japan -
Yasuko Terao, PHD Head, External Scientific Engagement, R&D Japan Region,
Takeda Pharmaceutical Co., Ltd., Japan -
Teruyo Arato, PHD Professor, Clinical Research and Medical Innovation Center
Hokkaido University Hospital, Japan -
Satoru Hayata, MS
Sobi Japan, Japan -
Ryutaro Hirasawa CMC Regulatory Affairs, Associate Director
Daiichi Sankyo Co., Ltd., Japan -
Akiko Ikeda, RPH PRIMO, External Researcher/Consultant
National Cancer Center, Japan -
Ikuo Kawauchi Senior Expert,International Standards Promotion Office,Intellectual Property Div
FUJIFILM Holdings Corporation, Japan -
Sumimasa Nagai, MD, PHD Institute for Advancement of Clinical and Translational Science(iACT)
Kyoto University Hospital, Japan -
Shinichi Noda, PHD Division Director, Division of Planning and Management, Office of International
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Hiroyuki Suda, MSC VP, Clinical Development Strategy
KORTUC Inc., Japan -
Yoshie Tsurumaki
HEALIOS K.K., Japan -
Keiji Miyamoto Principal Post-Marketing Regulatory Affairs Dep.
Daiichi Sankyo Co.,Ltd., Japan -
Akiko Nishioka Clinical Project Manager
Novartis Pharma K.K., Japan -
Yoji Sato, PHD Deputy Director General
National Institute of Health Sciences, Japan -
Masafumi Onodera, MD, PHD Director, Center of Gene Cell Therapy Promotion,
National Center for Child Health and Development, Japan
